Home/4Tissue/An Van Den Bulcke, PhD

AV

An Van Den Bulcke, PhD

Interim Chief Executive Officer, CBO/COO & Co-founder

Therapeutic Areas

Oncology (Reconstruction)Plastic & Reconstructive Surgery

4Tissue Pipeline

Drug	Indication	Phase
Tissurel®	Breast Reconstruction Post-Mastectomy	Pre-clinical

Leadership Team at 4Tissue

Lana Van Damme, MD, PhD

Chief Scientific Officer (CSO) & Co-founder

Prof. Phillip Blondeel

Prof. Dr. Sandra Van Vlierberghe

View full 4Tissue profile